123 results on '"Godkin, Andrew"'
Search Results
2. A targeted single mutation in influenza A virus universal epitope transforms immunogenicity and protective immunity via CD4+ T cell activation
3. Resolution of persistent SARS-CoV-2 infection with prolonged intravenous remdesivir and vaccination in a patient post CAR-T
4. Regulatory T Cells play a role in determining the tumourigenicity of the Intestinal Stem Cell Niche
5. Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4+ T cell immunity
6. Treg-driven tumour control by PI3Kδ inhibition limits myeloid-derived suppressor cell expansion
7. Magnitude of venous or capillary blood-derived SARS-CoV-2-specific T cell response determines COVID-19 immunity
8. The Dual Role of High Endothelial Venules in Cancer Progression versus Immunity
9. Prognostic significance of interleukin-17A-producing colorectal tumour antigen-specific T cells
10. Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group
11. The nature of the human T cell response to the cancer antigen 5T4 is determined by the balance of regulatory and inflammatory T cells of the same antigen-specificity: implications for vaccine design
12. Remarkably low affinity of CD4/peptide-major histocompatibility complex class II protein interactions
13. The Ussing chamber system for measuring intestinal permeability in health and disease
14. Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry
15. Effect of Modified Vaccinia Ankara–5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer: A Randomized Clinical Trial
16. Assessing the Prognostic Value of Preoperative Carcinoembryonic Antigen-Specific T-Cell Responses in Colorectal Cancer
17. More tricks with tetramers: a practical guide to staining T cells with peptide–MHC multimers
18. A distinct chemokine axis does not account for enrichment of Foxp3+ CD4+ T cells in carcinogen-induced fibrosarcomas
19. Progression of carcinogen-induced fibrosarcomas is associated with the accumulation of naïve CD4+ T cells via blood vessels and lymphatics
20. The paradox of NKp46+ natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatment
21. Rapid innate control of antigen abrogates adaptive immunity
22. COVID‐19 Vaccine Response in People with Multiple Sclerosis.
23. Regulating the immune response to tumours
24. Suppression of tumour-specific CD4+ T cells by regulatory T cells is associated with progression of human colorectal cancer
25. Paracetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunity
26. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope
27. Novel role of regulatory T cells in limiting early neutrophil responses in skin
28. Clinical characteristics of hepatitis E in a “Non-Endemic” population*
29. A distinctive peptide binding motif for HLA-DRB1 * 0407, an HLA-DR4 subtype not associated with rheumatoid arthritis
30. Regulatory T cells and tumour immunity – observations in mice and men
31. Pouring petrol on the flames: Using oncolytic virotherapies to enhance tumour immunogenicity.
32. Abdominal pain and melaena: an unusual cause
33. Expansion of hepatitis C-specific CD4+CD25+ regulatory T cells after viral clearance: A mechanism to limit collateral damage?
34. Molecular characterization of HLA class II binding to the LAG‐3 T cell co‐inhibitory receptor.
35. Primary breast tumours but not lung metastases induce protective anti-tumour immune responses after Treg-depletion.
36. VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium.
37. TCR‐induced alteration of primary MHC peptide anchor residue.
38. T‐cell modulation by cyclophosphamide for tumour therapy.
39. In Silico and structural analyses Demonstrate That intrinsic Protein Motions guide T cell receptor complementarity Determining region loop Flexibility.
40. Chronic infections with viruses or parasites: breaking bad to make good.
41. Cytomegalovirus-Specific IL-10-Producing CD4+ T Cells Are Governed by Type-I IFN-Induced IL-27 and Promote Virus Persistence.
42. A distinct chemokine axis does not account for enrichment of Foxp3+ CD4+ T cells in carcinogen-induced fibrosarcomas.
43. Structural basis for ineffective T-cell responses to MHC anchor residue-improved 'heteroclitic' peptides.
44. The paradox of NKp46+ natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatment.
45. Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology.
46. Home sweet home: the tumor microenvironment as a haven for regulatory T cells.
47. Re-directing CD4+ T cell responses with the flanking residues of MHC class II-bound peptides: the core is not enough.
48. Avidity of influenza-specific memory CD8+ T-cell populations decays over time compromising antiviral immunity.
49. Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4+ T-cell immunity.
50. Expansion of hepatitis C–specific CD4+CD25+ regulatory T cells after viral clearance: A mechanism to limit collateral damage?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.